ANSIRH News

Self-injection of the contraceptive DMPA

Subcutaneous DMPA (DMPA-SC), often known as “Depo Provera”, is a low-dose formulation that non-medical personnel can administer. The study sought to determine women’s interest in self-administration of DMPA-SC. Overall, 21% of women reported interest in self-administration, particularly if they were currently or had previously used DMPA. Women reporting difficulty obtaining or refilling a prescription were twice as likely to report interest in DMPA-SC compared to women with no difficulty. Interest was driven by a desire to reduce return visits to facilities for repeat injections.

In their own words: Experiences of women denied abortions

ANSIRH’s Global Turnaway Study team has released a beautifully animated short film portraying the personal stories of women across the world who face barriers to accessing legal abortion. The film highlights the experiences of women in Bangladesh, Colombia, Nepal, South Africa, Tunisia, and the United States.

ANSIRH study shows that few women visit pregnancy resource centers (PRCs) because they are considering abortion

The study looked at the reasons why women visit Pregnancy Resource Centers (PRCs), also known as crisis pregnancy centers (CPCs). The majority of women visiting the study PRC came for parenting resources, such as diapers and other childcare items. Only 2% of clients sought counseling on abortion.

ANSIRH Director Dan Grossman explains the sharp decline of abortions in Texas

The number of abortions in Texas dropped by 14 percent between 2013 and 2014. Legislators in the state saw the drop as a sign of reduced demand. However, research shows that barriers to care created by the law known as HB2, and not demand, is the likely cause in the steep decline.

Utah’s 72-hour waiting period law results in increased costs, burdens and anxiety

The study examines women’s decision-making, costs associated with each visit, actual wait times between the information visit and the abortion, and, through follow-up interviews, captures the voices of some of the 500 women who took part in the study identifying the hardest part of waiting and of making two visits.

Abortion does not increase risk of PTSD

New analysis from ANSIRH’s Turnaway Study data shows no increased risk of experiencing post-traumatic stress symptoms among women who have abortions compared to women who are denied abortions. In fact, risk declined over time for all study groups.

ANSIRH's Abortion Onscreen project examines portrayals of abortion on television over the last 10 years

Television storylines are, by design, more dramatic, bizarre, and fantastical than real life—and abortion storylines are no exception. Yet, when it comes to examining who gets (or thinks about getting) an abortion on TV, and how they compare to real women seeking abortion care, these fictional characters can impact how real world abortion patients are understood by the viewing public. These portrayals can skew political perceptions of women seeking abortion care, and contribute to ongoing abortion stigma.

Projections and opinions from 100 experts in long-acting reversible contraception

Experts on LARC, or long acting reversible contraception, think that there is significant room for growth in LARC uptake, but no universal belief in LARC as a “magic bullet.” In addition, there is virtually no support among LARC experts for potentially coercive policies aimed at incentivizing LARC provision or use.

The effect of abortion on having and achieving aspirational one-year plans

A new Turnaway Study analysis shows that women who received an abortion were more likely to have a positive outlook on the future and achieve aspirational life plans within one year than women denied an abortion. Women who had abortions had six times higher odds of expressing a positive life plan for the coming year than women who were denied abortion and carried the pregnancy to term. Positive life plans included goals related to education, employment, and living situation.

ANSIRH joins in celebrating 15 years of FDA approval for Mifepristone

ANSIRH Director, Dan Grossman, MD, wrote an op-ed for Newsweek titled “Hampering This Safe Abortion Method Is Cruel and Wrong,” and ANSIRH staff authored four papers in the special mifepristone anniversary issue of Contraception and published a new blog post on mifepristone.

In addition, read the new blog “Mifepristone at 15 : A cup half full” by ANSIRH researchers Ushma Upadhyay and Carole Joffe.

Main Menu

ANSIRH News

Self-injection of the contraceptive DMPA

In their own words: Experiences of women denied abortions

ANSIRH study shows that few women visit pregnancy resource centers (PRCs) because they are considering abortion

ANSIRH Director Dan Grossman explains the sharp decline of abortions in Texas

Utah’s 72-hour waiting period law results in increased costs, burdens and anxiety

Abortion does not increase risk of PTSD

ANSIRH's Abortion Onscreen project examines portrayals of abortion on television over the last 10 years

Projections and opinions from 100 experts in long-acting reversible contraception

The effect of abortion on having and achieving aspirational one-year plans

ANSIRH joins in celebrating 15 years of FDA approval for Mifepristone

Pages

New publications

New staff members

Contact us

Connect with us on social media

Main Menu

Search form

ANSIRH News

Pages

New publications

New staff members

Sign up for the ANSIRH Listserv

Contact us

Connect with us on social media